The JADE COMPARE study looked at how well and how safely abrocitinib treatment worked in adults with atopic dermatitis compared to placebo and dupilumab. This plain language summary describes the results of this study, originally published in the New England Journal of Medicine.
Read the full article here.
The original article, called ‘Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis’ was published in the New England Journal of Medicine and can be read here.